Consti Oyj
CONSTI PLC Managers Transactions on 12 February 2021 at 3.00 p.m.
Consti Plc - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Lähteinen, Pirkka
Position: Other senior manager
Issuer: Consti Plc
LEI: 743700JMXCC11CRJCS71
Notification type: INITIAL NOTIFICATION
Reference number: 743700JMXCC11CRJCS71_20210212135143_2
____________________________________________
Transaction date: 2021-02-12
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000178256
Nature of the transaction: DISPOSAL
Transaction details
(1): Volume: 3,500 Unit price: 12.25 EUR
Aggregated transactions
(1): Volume: 3,500 Volume weighted average price: 12.25 EUR
CONSTI PLC
Further information:
Joni Sorsanen, CFO, Consti Plc, Tel. +358 50 443 3045
Distribution:
Nasdaq Helsinki Ltd.
Major media
www.consti.fi
Consti is a leading Finnish company concentrating on renovation and technical services. Consti offers comprehensive renovation and building technology services and selected new construction services to housing companies, corporations, investors and the public sector in Finland’s growth centres. Company has four business areas: Housing Companies, Corporations, Public Sector and Building Technology. In 2020, Consti Group’s net sales amounted to 275 million euro. It employs approximately 1000 professionals in renovation construction and building technology.
Consti Plc is listed on Nasdaq Helsinki. The trading code is CONSTI. www.consti.fi
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd20.10.2025 22:30:00 CEST | Press release
Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe
Vicor Corporation20.10.2025 21:50:00 CEST | Press release
Vicor steps up its IP licensing practice
Biotalys NV20.10.2025 18:00:00 CEST | Press release
Regulated information
Syensqo SA20.10.2025 17:45:00 CEST | Press release
Syensqo - Acquisition of own shares
AACSB International20.10.2025 17:00:00 CEST | Press release
A New Era for Research Impact: AACSB, AOM, and Global Partners Invite Public Feedback on Landmark Framework
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom